At Charles River our focus is always on anticipating tomorrow’s drug development needs today and this is why we have invested in the tools, talent and capacity to further the new frontier of cell and gene therapy development. We can support your cell and gene therapy programs every step of the way, from early discovery, manufacturing of viral vectors, plasmid and autologous/allogenic cells, toxicity/toxicology studies, to analytical release testing of your cell line characterization, biosafety and potency testing.

Our global footprint and strategic relationships with key partners form a team of professionals and a portfolio of integrated services you need to get your product to patients faster.

To learn how we can help accelerate your cell and gene therapy goals, visit us at

Team Members

Jeff hung

Jeffrey Hung

General Manager - Vigene Biosciences, A Charles River Company


Luis Berrade

Director Sales Europe & LATAM


Philip Ridley-Smith

Sales and Marketing Director